Tuesday, May 6, 2008, 5:30 p.m. U.S. EDT
FRAZER, Pa., May 5 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) today announced plans to host an investor conference call at 5:30
p.m. EDT on May 6, 2008 to discuss the U.S. Food and Drug Administration
advisory committee panel meeting held that day. The advisory committee
panel is considering the company's supplemental New Drug Application for
FENTORA(R) (fentanyl buccal tablet) [C-II] for the management of
breakthrough pain in opioid-tolerant patients with chronic pain.
May 6, 2008 Schedule
5:20 p.m. EDT To participate in the conference call, dial 913-312-0407
and refer to Conference Code Number 2046179
5:30 p.m. EDT Conference call begins promptly.
Simultaneous Webcast
Investors can listen to the call live by logging on to the company's
website at http://www.cephalon.com and clicking on "Investor Information"
then "Webcast." Please click on the link and follow the prompts for
registration and access.
If you are unable to listen to the live broadcast, an audio or webcast
replay of the call will be available approximately two hours after the
event until Midnight EDT, May 20, 2008. To listen to the audio replay, dial
719- 457-0820 and use the Conference Code Number 2046179.
Additional information presented on the conference call may be made
available on the Investor Information page of the company's website.
SOURCE Cephalon, Inc.
 back to top
Related links:
http://www.cephalon.com
http://www.prnewswire.com/comp/134563.html/
CONTACT:
Robert S. (Chip) Merritt of Cephalon, Inc.,
+1-610-738-6376, cmerritt@cephalon.com
|
